Aspen Pharmacare (LDZU) Ratios
Aspen Pharmacare Ratios
DE:LDZU's free cash flow for Q4 2026 was $2.50B. For the 2026 fiscal year, DE:LDZU's free cash flow was decreased by $-1.11B and operating cash flow was $3.61B. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.54 | 2.21 | 1.81 | 1.92 | 1.48 |
| Quick Ratio | 1.68 | 1.18 | 1.07 | 1.08 | 0.80 |
| Cash Ratio | 0.99 | 0.37 | 0.51 | 0.47 | 0.26 |
| Solvency Ratio | 0.16 | 0.02 | 0.12 | 0.14 | 0.19 |
| Operating Cash Flow Ratio | 0.42 | 0.29 | 0.26 | 0.24 | 0.23 |
| Short-Term Operating Cash Flow Coverage | 1.12 | 1.12 | 0.56 | 0.71 | 0.47 |
| Net Current Asset Value | $ 13.27B | $ -12.30B | $ -10.21B | $ -3.55B | $ -5.87B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.14 | 0.27 | 0.26 | 0.22 | 0.20 |
| Debt-to-Equity Ratio | 0.19 | 0.43 | 0.43 | 0.34 | 0.31 |
| Debt-to-Capital Ratio | 0.16 | 0.30 | 0.30 | 0.25 | 0.24 |
| Long-Term Debt-to-Capital Ratio | 0.11 | 0.27 | 0.23 | 0.20 | 0.13 |
| Financial Leverage Ratio | 1.35 | 1.60 | 1.64 | 1.56 | 1.57 |
| Debt Service Coverage Ratio | 0.89 | 0.42 | 0.65 | 0.98 | 0.67 |
| Interest Coverage Ratio | 3.51 | 0.87 | 3.14 | 5.91 | 11.33 |
| Debt to Market Cap | 0.23 | 0.68 | 0.36 | 0.36 | 0.33 |
| Interest Debt Per Share | 38.17 | 85.03 | 87.08 | 68.90 | 50.80 |
| Net Debt to EBITDA | -0.06 | 8.22 | 2.44 | 1.80 | 1.62 |
| Profitability Margins | |||||
| Gross Profit Margin | 40.31% | 44.11% | 43.43% | 45.22% | 47.42% |
| EBIT Margin | 15.48% | 3.52% | 17.76% | 21.93% | 22.64% |
| EBITDA Margin | 20.98% | 8.34% | 22.16% | 25.03% | 25.73% |
| Operating Profit Margin | 15.48% | 3.31% | 15.65% | 19.21% | 22.46% |
| Pretax Profit Margin | -1.20% | -0.28% | 12.78% | 16.10% | 21.07% |
| Net Profit Margin | 7.59% | -2.50% | 9.85% | 12.84% | 16.81% |
| Continuous Operations Profit Margin | -2.55% | -2.50% | 9.85% | 12.84% | 16.81% |
| Net Income Per EBT | -633.25% | 880.49% | 77.07% | 79.76% | 79.76% |
| EBT Per EBIT | -7.74% | -8.56% | 81.65% | 83.80% | 93.81% |
| Return on Assets (ROA) | 2.41% | -0.80% | 3.16% | 3.89% | 5.83% |
| Return on Equity (ROE) | 3.25% | -1.28% | 5.19% | 6.06% | 9.15% |
| Return on Capital Employed (ROCE) | 5.79% | 1.21% | 6.10% | 7.04% | 9.86% |
| Return on Invested Capital (ROIC) | 5.43% | 1.17% | 4.28% | 5.24% | 6.94% |
| Return on Tangible Assets | 4.03% | -1.71% | 6.54% | 7.97% | 12.31% |
| Earnings Yield | 3.79% | -2.03% | 4.40% | 6.41% | 9.80% |
| Efficiency Ratios | |||||
| Receivables Turnover | 68.29 | 3.25 | 3.90 | 4.04 | 4.68 |
| Payables Turnover | 2.19 | 2.27 | 5.78 | 5.62 | 5.58 |
| Inventory Turnover | 1.47 | 1.35 | 1.40 | 1.14 | 1.29 |
| Fixed Asset Turnover | 1.67 | 2.00 | 2.18 | 2.15 | 2.38 |
| Asset Turnover | 0.32 | 0.32 | 0.32 | 0.30 | 0.35 |
| Working Capital Turnover Ratio | 1.48 | 2.12 | 2.18 | 2.50 | 10.84 |
| Cash Conversion Cycle | 87.42 | 222.74 | 290.32 | 346.37 | 295.89 |
| Days of Sales Outstanding | 5.34 | 112.28 | 93.61 | 90.44 | 77.93 |
| Days of Inventory Outstanding | 248.54 | 271.24 | 259.82 | 320.89 | 283.42 |
| Days of Payables Outstanding | 166.46 | 160.78 | 63.10 | 64.96 | 65.47 |
| Operating Cycle | 253.88 | 383.52 | 353.42 | 411.33 | 361.36 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 15.15 | 11.61 | 14.01 | 12.43 | 11.86 |
| Free Cash Flow Per Share | 10.42 | 0.23 | 1.55 | 5.27 | 5.91 |
| Dividend Paid and CapEx Coverage Ratio | 2.23 | 0.78 | 0.88 | 1.19 | 1.38 |
| Capital Expenditure Coverage Ratio | 3.21 | 1.02 | 1.12 | 1.74 | 1.99 |
| Operating Cash Flow Coverage Ratio | 0.44 | 0.14 | 0.17 | 0.19 | 0.24 |
| Operating Cash Flow to Sales Ratio | 0.20 | 0.12 | 0.14 | 0.14 | 0.14 |
| Free Cash Flow Yield | 6.76% | 0.20% | 0.69% | 2.87% | 4.04% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 26.62 | -49.19 | 22.73 | 15.61 | 10.21 |
| Price-to-Sales (P/S) Ratio | 2.00 | 1.23 | 2.24 | 2.01 | 1.72 |
| Price-to-Book (P/B) Ratio | 0.86 | 0.63 | 1.18 | 0.95 | 0.93 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 14.78 | 512.59 | 145.09 | 34.90 | 24.74 |
| Price-to-Operating Cash Flow Ratio | 10.17 | 10.33 | 16.08 | 14.79 | 12.32 |
| Price-to-Earnings Growth (PEG) Ratio | -0.08 | 0.39 | -1.44 | -0.88 | 0.28 |
| Enterprise Value Multiple | 9.49 | 22.97 | 12.54 | 9.81 | 8.28 |
| Enterprise Value | 68.01B | 83.02B | 124.23B | 99.99B | 82.29B |
| EV to EBITDA | 9.49 | 22.97 | 12.54 | 9.81 | 8.28 |
| EV to Sales | 1.99 | 1.91 | 2.78 | 2.46 | 2.13 |
| EV to Free Cash Flow | 14.69 | 798.27 | 180.04 | 42.75 | 30.74 |
| EV to Operating Cash Flow | 10.11 | 16.09 | 19.96 | 18.11 | 15.31 |
| Tangible Book Value Per Share | 82.60 | 28.09 | 29.37 | 39.48 | 27.12 |
| Shareholders’ Equity Per Share | 179.53 | 191.11 | 191.04 | 194.14 | 156.60 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -1.12 | -7.80 | 0.23 | 0.20 | 0.20 |
| Revenue Per Share | 76.88 | 97.62 | 100.64 | 91.65 | 85.22 |
| Net Income Per Share | 5.84 | -2.44 | 9.91 | 11.77 | 14.32 |
| Tax Burden | -6.33 | 8.80 | 0.77 | 0.80 | 0.80 |
| Interest Burden | -0.08 | -0.08 | 0.72 | 0.73 | 0.93 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| SG&A to Revenue | 0.25 | 0.25 | 0.08 | 0.04 | 0.04 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -7.74 | 3.59 | 0.89 | 0.71 | 0.62 |
Currency in ZAR